Oncotarget

Research Papers:

Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function

Anders E. Berglund, Kristen E.N. Scott, Weimin Li, Chunying Yang, Mario R. Fernandez, Franz X. Schaub, John L. Cleveland and Robert J. Rounbehler _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:83462-83475. https://doi.org/10.18632/oncotarget.13128

Metrics: PDF 740 views  |   HTML 931 views  |   ?  


Abstract

Anders E. Berglund1,*, Kristen E.N. Scott2,*, Weimin Li2, Chunying Yang2, Mario R. Fernandez2,3, Franz X. Schaub2, John L. Cleveland2,3, Robert J. Rounbehler2,3

1Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA

2Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA

3Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA

*These authors have contributed equally to this article

Correspondence to:

Robert J. Rounbehler, email: Robert.Rounbehler@moffitt.org

Keywords: prostate cancer, tristetraprolin, TTP, metabolism, proliferation

Received: August 04, 2016     Accepted: October 19, 2016     Published: November 05, 2016

ABSTRACT

Tristetraprolin (TTP) is an RNA-binding protein that post-transcriptionally suppresses gene expression by delivering mRNA cargo to processing bodies (P-bodies) where the mRNA is degraded. TTP functions as a tumor suppressor in a mouse model of B cell lymphoma, and in some human malignancies low TTP expression correlates with reduced survival. Here we report important prognostic and functional roles for TTP in human prostate cancer. First, gene expression analysis of prostate tumors revealed low TTP expression correlates with patients having high-risk Gleason scores and increased biochemical recurrence. Second, in prostate cancer cells with low levels of endogenous TTP, inducible TTP expression inhibits their growth and proliferation, as well as their clonogenic growth. Third, TTP functions as a tumor suppressor in prostate cancer, as forced TTP expression markedly impairs the tumorigenic potential of prostate cancer cells in a mouse xenograft model. Finally, pathway analysis of gene expression data suggested metabolism is altered by TTP expression in prostate tumor cells, and metabolic analyses revealed that such processes are impaired by TTP, including mitochondrial respiration. Collectively, these findings suggest that TTP is an important prognostic indicator for prostate cancer, and augmenting TTP function would effectively disable the metabolism and proliferation of aggressive prostate tumors.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 13128